CausalSentinel

Protein Dossier — PLG (Plasminogen)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Weight 0.0212 0.00609 5.16e-04 Wald ratio 1 cis NA
Coronary heart disease -0.103 0.0303 6.29e-04 Wald ratio 1 cis NA
Amygdala volume 21.8 7.02 0.00192 Wald ratio 1 cis NA
Non-cancer illness code self-reported: high cholesterol -0.0589 0.0198 0.00293 Wald ratio 1 cis NA
Body mass index (BMI) 0.02 0.0069 0.00375 Wald ratio 1 cis NA
Non-cancer illness code self-reported: bone disorder 0.288 0.112 0.01 Wald ratio 1 cis NA
Diastolic blood pressure automated reading 0.0178 0.00706 0.0117 Wald ratio 1 cis NA
Systolic blood pressure automated reading 0.0169 0.00705 0.0165 Wald ratio 1 cis NA
Alcohol intake frequency -0.0239 0.0102 0.0193 Wald ratio 1 cis NA
Fractured bone site(s): Arm -0.196 0.0852 0.0216 Wald ratio 1 cis NA
Diagnoses - main ICD10: C61 Malignant neoplasm of prostate -0.222 0.107 0.0386 Wald ratio 1 cis NA
Fractured bone site(s): Other bones 0.0584 0.0283 0.0392 Wald ratio 1 cis NA
…and 77 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3710_49_2 Angiostatin Suhre K 2019
prot-c-4150_75_2 Plasmin Suhre K 2019
prot-c-4151_6_2 Plasminogen Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

1122 association rows across 433 traits (1073 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Lipoprotein A levels (UKB data field 30790) 1e-300 rs76832359 21 GCST90134488 no MR -> candidate analysis
Lipoprotein (a) levels 8e-285 rs56393506 41 GCST004398 no MR -> candidate analysis
PLG protein levels 2e-284 rs4252129 15 GCST90470257 no MR -> candidate analysis
Cholesterol to Total Lipids in Very Large VLDL percentage 8e-281 rs56393506 2 GCST90500518 no MR -> candidate analysis
LPA protein levels 1e-256 rs783184 19 GCST90469786 no MR -> candidate analysis
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoform 2e-207 rs186696265 4 GCST004399 no MR -> candidate analysis
Phospholipids to Total Lipids in Chylomicrons and Extremely 4e-182 rs56393506 3 GCST90501339 no MR -> candidate analysis
Angiostatin levels 2e-178 rs537579467 6 GCST90246505 no MR -> candidate analysis
LDL cholesterol levels x alcohol consumption (drinkers vs no 2e-178 rs5014650 2 GCST008079 no MR -> candidate analysis
Plasminogen levels 3e-176 rs144981713 6 GCST90249026 no MR -> candidate analysis
Free Cholesterol to Total Lipids in Large VLDL percentage 6e-148 rs56393506 1 GCST90501163 no MR -> candidate analysis
Coronary artery disease 9e-116 rs186696265 11 GCST90132314 MR: beta=-0.103, p=6.29e-04 (cis)
…and 421 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 3178 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hypoplasminogenemia 0.899 established (curated) no MR -> candidate analysis
hereditary angioedema 0.867 established (curated) no MR -> candidate analysis
dysplasminogenemia 0.745 established (curated) no MR -> candidate analysis
myocardial infarction 0.751 common-variant locus MR: beta=-0.0634, p=0.0597 (cis)
coronary artery disorder 0.804 common-variant locus no MR -> candidate analysis
atrial fibrillation 0.779 common-variant locus MR: beta=0.0986, p=0.0972 (cis)
cardiovascular disorder 0.79 common-variant locus no MR -> candidate analysis
Hypercholesterolemia 0.738 common-variant locus MR: beta=-0.0589, p=0.00293 (cis)
hyperlipidemia 0.704 common-variant locus no MR -> candidate analysis
temporal arteritis 0.683 common-variant locus no MR -> candidate analysis
heart disorder 0.672 common-variant locus no MR -> candidate analysis
metabolic syndrome 0.64 common-variant locus no MR -> candidate analysis
metabolic disease 0.635 common-variant locus no MR -> candidate analysis
abnormal chest sounds 0.633 common-variant locus no MR -> candidate analysis
coronary atherosclerosis 0.623 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 12 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 9 known modulators (Plasminogen)
gnomAD constraint pLI=0.76, LOEUF=0.51 — LoF-tolerant
GWAS Catalog 268 unique SNPs / 698 rows
ClinVar 671 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance